EPT Fumarate: A Novel Therapeutic Agent for Mitochondrial Dysfunction
Mitochondrial dysfunction plays a wide range of complex diseases. This deficiency in mitochondrial function can lead to cellular stress, ultimately resulting in multiple pathologies. EPT Fumarate, a novel therapeutic agent, has emerged as a promising strategy for addressing this debilitating issue. EPT Fumarate functions by enhancing the activity